Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-15-016285
Filing Date
2015-12-15
Accepted
2015-12-15 16:34:28
Documents
1
Period of Report
2015-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 7347
  Complete submission text file 0001179110-15-016285.txt   8556
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421
Business Address
Gollust Keith R (Reporting) CIK: 0001325712 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 151288861